Recall Record

Redwood City, CA, United States

AURIS HEALTH INC recalls

5 recalls recorded since 2018, most recently on 21 January 2026. 4 are listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)4
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
21 January 2026
Reason
Device for bronchoscopic visualization, patient airway access has software issue: if application restarts after patient-side selection, prior to bronchoscope loading, application will re-initialize to patient-left position; and if right position was previously selected, this may lead to unanticipated robotic arm positioning toward patient-left, may result in contact with patient/endotracheal tube.
Distribution
Worldwide - US Nationwide distribution in the states of MN, FL, NJ, NY, VA, WI, AZ, AL, MS, LA, MI, MA, MT, PA, WV, GA, DE, TX, CA, OH, IN, SC, CT, ND, MO, DC, IL, NE, ID, WA, NC, TN, OR, CO, SD, NM, VT, MD and the countries of Hong Kong, China, Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1383-2026

Ongoing Class II Medical devices

Recall started
18 October 2025
Reason
Potential that product was leak tested with equipment outside of its expected operating range, resulting in bronchoscopes that may not be susceptible to leaks.
Distribution
Nationwide distribution to AL, AZ, CA, CO, CT, DC, FL, GA, ID, IL, IN, KY, MA, MI, MS, MT, NC, NE, NJ, NM, NY, OH, OR, PA, SC, SD, TN, VA, VT, WA, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-0543-2026

Ongoing Class II Medical devices

Recall started
2 August 2024
Reason
Endoscopy/bronchoscopy/urology devices may have a strain relief defect with some cart and tower power cords that may cause an electrical short, which may lead to system shutdown, which can lead to prolonged procedure or case conversion, and if the user (e.g., operating room staff) touches exposed wires or conductive fluids in contact with the exposed wires, there is a chance of electrical shock.
Distribution
Worldwide - US Nationwide distribution including in the states of MN, FL, NC, AK, NJ, NY, VA, WI, AZ, MS, LA, MI, MA, MT, WV, GA, DE, TX, CA, OH, IN, SC, PA, CT, ND, MO, DC, IL, NE, ID, WA, TN, OR, AL, SD, CO, KY, NM, VT, MD and the countries of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0051-2025, Z-0052-2025

Ongoing Class II Medical devices

Recall started
18 October 2023
Reason
Their is the potential that software issues may result in flipped image of the virtual Bronchoscope view.
Distribution
US Distribution: AK, AL, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KY, MA, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NY, OH, OR, PA, SC, SD, TN, TX, WI & WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0450-2024, Z-0449-2024, Z-0448-2024

Terminated Class II Medical devices

Recall started
19 April 2019
Terminated
19 January 2022
Reason
Reports of aspirating biopsy needle breakage
Distribution
US nationwide distribution to the states of: CT, FL, MI, OK, TN, MS, CA, MN, OH, PA, and IL.
Initiated
Voluntary: Firm initiated
Recall number
Z-0025-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.